News from bionity.com

Defective Epithelial Barriers Linked to Two Billion Chronic Diseases

Humans are exposed to a variety of toxins and chemicals every day. According to the epithelial barrier hypothesis, exposure to many of these substances damages the epithelium, the thin layer of cells that covers the surface of our skin, lungs and intestine. Defective epithelial barriers have been li...

more…

Inactivating pathogens using low-energy electrons

Vaccines are currently a great source of hope for many people, as it is believed they will help to protect society against COVID-19 and pave the way back to a normal life. The current focus is clearly on coronavirus – but vaccines are also fundamental to combating other pathogens. A team of research...

more…

Cellphone converts into powerful chemical detector

Scientists from Texas A&M have developed an extension to an ordinary cellphone that turns it into an instrument capable of detecting chemicals, drugs, biological molecules, and pathogens. The advance is reported in Reviews of Scientific Instruments, by AIP Publishing. Modern cellphones include high-...

more…

Solving the oldest problem in microbiology

The European Patent Office (EPO) announces that renowned US microbiologists Kim Lewis and Slava S. Epstein have been nominated as finalists in the "Non-EPO countries" category of the European Inventor Award 2021. They have developed a device that enables scientists to separate and incubate single st...

more…

Tracking down the tiniest of forces: how T cells detect invaders

T-cells play a central role in our immune system: by means of their so-called T-cell receptors (TCR) they make out dangerous invaders or cancer cells in the body and then trigger an immune reaction. On a molecular level, this recognition process is still not sufficiently understood. Intriguing obser...

more…

Eppendorf achieves record revenue and best result in the company’s history in 2020

In fiscal year 2020, Eppendorf AG succeeded in posting record revenue of €967 million (prior year: €804 million) – a significant year-on-year increase of 20.3% (prior year: 10.2%). EBIT likewise saw a sharp rise of €73.5 million to €217.7 million (prior year: €144.2 million), representing an improve...

more…

New dimension for efficient laboratory work

With the successful completion of a second closing, Labforward adds >€3m to the Series B from January, bringing the total funds raised to >€8.5m. The majority of the new investment comes from the Fielmann Family Office, majority owner of the leading German family business of the same name that serve...

more…

CatalYm Appoints Industry Leader Dr. Phil L’Huillier as Chief Executive Office

CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, announced the appointment of Dr. Phil L’Huillier as Chief Executive Officer (CEO), effective May 17, 2021. Dr. Phil L’Huillier brings over two decades of experience in executive leadership positions in the pharmaceuti...

more…

Heavy charge against water germs

Removing pathogens from drinking water is especially difficult when the germs are too tiny to be caught by conventional filters. Researchers at Empa and Eawag are developing new materials and processes to free water from pathogenic microorganisms such as viruses Water is life, biology teaches us. Re...

more…

BASF strengthens its global production footprint for enzymes

On April 26, 2021 BASF has agreed with Sandoz GmbH, a subsidiary of Novartis, to invest at the Kundl/Schaftenau Campus in Austria. This agreement enables BASF to further develop its production footprint for enzymes and biotechnology products. Both parties agreed not to disclose financial details of ...

more…